Boston Trust Walden Corp trimmed its position in shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) by 0.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 662,015 shares of the medical device company’s stock after selling 3,118 shares during the […]
Teza Capital Management LLC grew its position in shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) by 13.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,454 shares of the medical device company’s stock after acquiring an additional 653 shares during the quarter. Teza Capital Management […]
Zurcher Kantonalbank Zurich Cantonalbank lessened its stake in shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) by 2.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,104 shares of the medical device company’s stock after selling 362 shares during the quarter. Zurcher […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Globus Medical, Inc. (NYSE:GMED – Get Rating) SVP Kelly Huller sold 2,500 shares of the company’s stock in a transaction on Friday, April 8th. The stock was sold at an average price of $75.58, for a total value of $188,950.00. The sale was disclosed in a filing with the SEC, which is accessible through this […]